WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC (EIN 871500208) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

GARY A DAHL

Phone

6087291450

Tax Period

2024-01-01 to 2024-12-31

WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC, founded in 2021, is a community nonprofit in the Medical Research sector that reported $2.1M in total revenue in fiscal year 2024. Revenue surged 224% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.6M, a strong 80% operating margin.

Mission

THE ORGANIZATION'S PRIMARY EXEMPT PURPOSE IS TO ENGAGE IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH A HOSPITAL.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,027,000

Program Service Revenue $13,755

Investment Income $9,617

Other Revenue $0

TOTAL REVENUE $2,050,372

Expense Breakdown

Grants Paid $0

Salaries & Benefits $341,677

Fundraising Expenses $0

Program Expenses $350,818

Other Expenses $63,277

TOTAL EXPENSES $404,954

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,050,372	$633,133	+2.2%
Expenses	$404,954	$711,144	-0.4%
Net Income	$1,645,418	$-78,011	-22.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GARY A DAHL	PRESIDENT	1.00	Officer Director	$0	$0	$0
JEROME J JENDRISAK	VP, SEC/TREA	1.00	Officer Director	$0	$0	$0
KIERAN COE	DIRECTOR	0.10	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,050,372	$404,954	$1,823,568	$1,645,418
2023	$633,133	$711,144	$192,955	$-78,011
2022	$500,000	$292,215	$265,501	$207,785

WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC